BRITTANY MCCALL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NORWICH, CT NPI 1861997751
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CT E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$492.45
- Category: General Payments
- Program years: PY2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $492.45 across 22 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $492.45 | 22 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $106.98 | 2 |
| Janssen Biotech, Inc. | $40.54 | 2 |
| Acerta Pharma LLC | $38.13 | 2 |
| Astellas Pharma US Inc | $36.44 | 2 |
| SOBI, INC | $27.48 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.25 | 1 |
| PFIZER INC. | $25.63 | 1 |
| ADC Therapeutics America, Inc. | $24.03 | 1 |
| Genentech USA, Inc. | $22.95 | 1 |
| PharmaEssentia USA Corporation | $22.88 | 1 |
| Lilly USA, LLC | $20.82 | 1 |
| Celgene Corporation | $18.62 | 1 |
| EISAI INC. | $17.75 | 1 |
| Daiichi Sankyo Inc. | $16.80 | 1 |
| Merck Sharp & Dohme Corporation | $15.90 | 1 |
| Incyte Corporation | $15.63 | 1 |
| Karyopharm Therapeutics Inc. | $15.62 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $492.45 | 22 |
Records — PY2024 (22)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.